U&I Corporation (056090) - Total Assets
Based on the latest financial reports, U&I Corporation (056090) holds total assets worth ₩126.07 Billion KRW (≈ $85.44 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore U&I Corporation cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
U&I Corporation - Total Assets Trend (2015–2025)
This chart illustrates how U&I Corporation's total assets have evolved over time, based on quarterly financial data. See 056090 net assets for net asset value and shareholders' equity analysis.
U&I Corporation - Asset Composition Analysis
Current Asset Composition (December 2025)
U&I Corporation's total assets of ₩126.07 Billion consist of 30.5% current assets and 69.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 9.1% |
| Accounts Receivable | ₩7.25 Billion | 6.3% |
| Inventory | ₩15.39 Billion | 13.4% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩4.33 Billion | 3.8% |
| Goodwill | ₩6.65 Billion | 5.8% |
Asset Composition Trend (2015–2025)
This chart illustrates how U&I Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of U&I Corporation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: U&I Corporation's current assets represent 30.5% of total assets in 2025, a decrease from 78.6% in 2015.
- Cash Position: Cash and equivalents constituted 9.1% of total assets in 2025, down from 16.8% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 2015.
- Asset Diversification: The largest asset category is inventory at 13.4% of total assets.
U&I Corporation Competitors by Total Assets
Key competitors of U&I Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Medtronic PLC
XETRA:2M6
|
Germany | €91.57 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Aroa Biosurgery Ltd
AU:ARX
|
Australia | AU$95.27 Million |
|
EBR Systems Inc
AU:EBR
|
Australia | AU$97.29 Million |
|
MICROPORT CARDIO.MEDTECH.
F:72X
|
Germany | €2.67 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
U&I Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.55 | 4.69 | 1.12 |
| Quick Ratio | 1.57 | 3.58 | 0.66 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩25.37 Billion | ₩41.48 Billion | ₩2.69 Billion |
U&I Corporation - Advanced Valuation Insights
This section examines the relationship between U&I Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.14 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 7.2% |
| Total Assets | ₩114.92 Billion |
| Market Capitalization | $72.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values U&I Corporation's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: U&I Corporation's assets grew by 7.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for U&I Corporation (2015–2025)
The table below shows the annual total assets of U&I Corporation from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩114.92 Billion ≈ $77.88 Million |
+7.20% |
| 2024-12-31 | ₩107.20 Billion ≈ $72.65 Million |
+35.53% |
| 2023-12-31 | ₩79.10 Billion ≈ $53.60 Million |
-44.08% |
| 2022-12-31 | ₩141.44 Billion ≈ $95.85 Million |
+88.43% |
| 2021-12-31 | ₩75.06 Billion ≈ $50.87 Million |
+16.50% |
| 2020-12-31 | ₩64.43 Billion ≈ $43.66 Million |
-9.35% |
| 2019-12-31 | ₩71.08 Billion ≈ $48.17 Million |
-5.05% |
| 2018-12-31 | ₩74.86 Billion ≈ $50.73 Million |
-5.33% |
| 2017-12-31 | ₩79.08 Billion ≈ $53.59 Million |
+19.52% |
| 2016-12-31 | ₩66.16 Billion ≈ $44.84 Million |
-14.55% |
| 2015-12-31 | ₩77.42 Billion ≈ $52.47 Million |
-- |
About U&I Corporation
CG MedTech Co.,Ltd. researches, develops, manufactures, and sale of orthopedic medical devices in the healthcare service market. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cerv… Read more